Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran.
about
Interventions for Old World cutaneous leishmaniasisTreatment of Cutaneous Leishmaniasis Caused by Leishmania aethiopica: A Systematic ReviewMiltefosine for visceral and cutaneous leishmaniasis: drug characteristics and evidence-based treatment recommendationsMiltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasisDynamics of parasite clearance in cutaneous leishmaniasis patients treated with miltefosineGenetic polymorphisms and drug susceptibility in four isolates of Leishmania tropica obtained from Canadian soldiers returning from AfghanistanGene disruption of the DNA topoisomerase IB small subunit induces a non-viable phenotype in the hemoflagellate Leishmania majorUpdate in the treatment of cutaneous leishmaniasis.Nutritional status in patients with cutaneous leishmaniasis and a study of the effects of zinc supplementation together with antimony treatment.Evaluation of a Novel Herbal Immunomodulator Drug (IMOD) in Treatment of Experimental Canine Visceral leishmaniasisCutaneous leishmaniasis after travel to Cyprus and successful treatment with miltefosineAn update on pharmacotherapy for leishmaniasisIn Vitro Study of Leishmanicidal Activity of Biogenic Selenium Nanoparticles against Iranian Isolate of Sensitive and Glucantime-Resistant Leishmania tropica.Species-directed therapy for leishmaniasis in returning travellers: a comprehensive guideCutaneous leishmaniasis: recent developments in diagnosis and managementComparison between Combination Therapy of Oral Terbinafine and Cryotherapy versus Systemic Meglumine Antimoniate and Cryotherapy in Cutaneous Leishmaniasis: A Randomized Clinical Trial.Trend of cutaneous leishmaniasis in kermanshah province, west of iran from 1990 to 2012.Noninferiority of miltefosine versus meglumine antimoniate for cutaneous leishmaniasis in childrenTherapeutic effect of sodium selenite and zinc sulphate as supplementary with meglumine antimoniate( glucantime®) against cutaneous leishmaniasis in BALB/c miceDevelopment of a novel formulation with hypericin to treat cutaneous leishmaniasis based on photodynamic therapy in in vitro and in vivo studies.Thermotherapy. An alternative for the treatment of American cutaneous leishmaniasisPharmacokinetics of miltefosine in Old World cutaneous leishmaniasis patients.Old World cutaneous leishmaniasis: diagnosis and treatmentTreatment of leishmaniasis with miltefosine: 2008 status.Treatment of cutaneous leishmaniasis in travelers 2009.First Report on Infant Acute Urticaria after Mother's Parenteral Use of Meglumine Antimoniate (Glucantime): A Case Report.Pharmacokinetics of Miltefosine in Children and Adults with Cutaneous Leishmaniasis.Cutaneous and mucocutaneous leishmaniasis: emerging therapies and progress in disease management.Leishmaniasis: new insights from an old and neglected disease.Therapy of vector-borne protozoan infections in nonendemic settings.Drug delivery systems for the topical treatment of cutaneous leishmaniasis.Local or systemic treatment for New World cutaneous leishmaniasis? Re-evaluating the evidence for the risk of mucosal leishmaniasis.Therapeutic options for old world cutaneous leishmaniasis and new world cutaneous and mucocutaneous leishmaniasis.Parasitic diseases in travelers: a focus on therapy.LeishMan recommendations for treatment of cutaneous and mucosal leishmaniasis in travelers, 2014.Cutaneous leishmaniasis in travellers: a focus on epidemiology and treatment in 2015.The antileishmanial effects of Lowsonia inermis and Cedrus libani on Leishmania major promastigotes: an in vitro study.Miltefosine for Mucosal and Complicated Cutaneous Old World Leishmaniasis: A Case Series and Review of the Literature.Clinical Response with intralesional Amphotericin B in the treatment of old world cutaneous leishmaniasis: a preliminary report.Chemotherapy of leishmaniasis: present challenges.
P2860
Q24241245-C1453C52-D4CE-421F-A038-006C3E7DDC91Q26764786-4E8EF66C-AE74-4B24-8625-7C23CA28EAA7Q28088410-7920706E-84C1-49B6-A52E-48904C3757DAQ28271849-1CD18982-D8B5-4D9E-9EDF-C624293669D5Q28478376-20B39856-17B9-4C01-8B7F-D818556544E5Q28478944-E7C61ADD-640A-41FC-AF3D-495FAF96129BQ33350046-7DEB5760-BDDD-4825-8AF6-35C7A92DE6DAQ34421618-FB6B934E-2044-4CCB-BDF2-65151EC88F76Q34474454-9A3A2CF2-5178-437E-B40D-017917A8E7D2Q34515998-3232D6B6-85F6-40D1-9FD9-7182EAD537A0Q34707796-D729F3AC-9A47-485F-867E-3F2C44F0E101Q34945204-F7FD936E-1812-4171-A429-03A5A632F3B6Q35133185-DFCDD019-02A8-4B63-A5FD-63EC9388AE36Q35160905-EF1E3CF9-D63A-46CC-8C71-149CD702A4A4Q35187729-0D6533B8-81AD-4D60-87CD-1E54111C8631Q35489435-DEA131B2-2D3D-4CA9-A622-DF1F005C6D66Q35489524-DFDF0281-5278-4A25-9598-AEEE8B1989BBQ35694752-23075AAE-0A87-4289-B457-F010C5DA86C6Q35758065-D3A61026-C61E-4309-B4B6-04329814FFDCQ35960805-18224BDE-84F5-4B64-9DB4-947643D2FD52Q36232091-0CC7703E-F0BD-4161-B758-329524E7A9A2Q36803937-DAD7C8BA-F288-42DC-8831-953AE4289DFAQ37010084-39BAF515-1898-4CD5-B589-CECC31A7F4EEQ37249719-64649449-0EC0-4627-8B25-921513EE020DQ37428084-1D9C608C-B900-42B3-A0AE-D205B06B4848Q37491894-445B5A4A-F8D8-44F3-94E6-B94F2F0D19EFQ37669845-9F132119-D026-4FFD-9532-8D2A988C7E63Q37693923-661675B6-B47E-4780-A31A-1F7012803880Q37870821-B5F830D4-09E4-46AF-8D68-E118E4B3212FQ37879203-5E479009-61BB-450D-AC09-C2ED2ECCD102Q38020882-2C0B8581-E539-4FC7-AB27-26FFD95A9E24Q38136837-F9A21CEC-55CE-4951-8B85-627B5CD3DB3CQ38156421-3F2BE257-9846-401E-B039-B9E417867FE3Q38192001-81A60D74-F2FD-4981-BD74-E051BE33162CQ38205451-EC9B7D1A-729B-4C5F-B206-1CCF0728223BQ38511211-057717CB-639D-4F24-985F-E2C11AFE7B04Q38670961-D9A5519F-A59A-4F75-939E-8382CEDA0D21Q38797460-F8AAD006-47AD-415D-ADA5-5A9247FE0319Q38914470-B1F6BB10-4937-40D1-816B-DB0753E92F51Q39011875-3FD7590A-9988-4B92-9C6D-46887746C985
P2860
Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Comparison of miltefosine and ...... omized clinical trial in Iran.
@en
Comparison of miltefosine and ...... onotic cutaneous leishmaniasis
@nl
type
label
Comparison of miltefosine and ...... omized clinical trial in Iran.
@en
Comparison of miltefosine and ...... onotic cutaneous leishmaniasis
@nl
prefLabel
Comparison of miltefosine and ...... omized clinical trial in Iran.
@en
Comparison of miltefosine and ...... onotic cutaneous leishmaniasis
@nl
P2093
P1433
P1476
Comparison of miltefosine and ...... omized clinical trial in Iran.
@en
P2093
Akhoundi B
Hooshmand B
Mohebali M
Razaghian AR
P356
10.1016/J.ACTATROPICA.2007.05.005
P577
2007-05-18T00:00:00Z